Clicky

Instituto Hermes Pardini S.A(PARD3)

Description: Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. The company offers precision medicine, medical imaging, and unprecedented differentials in the field of forensic toxicology, occupational medicine, and clinical medicine, as well as sample collection services for clinical analysis tests, imaging tests, and vaccines. In addition, it engages in the resale of laboratory test supplies; personalized medicine diagnosis; and pathological anatomy business. The company primarily operates through Hermes Pardini, Padrão, Progenética, Diagnóstika, Cemedi, Centro de Medicina, Ecoar, Labclass Hermes Pardini, DLE, Toxicologia Pardini, Solução, APC, CLINICA DE IMAGEM, and Saúde Mob brand names. It serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is based in Belo Horizonte, Brazil.


Keywords: Medicine Imaging Medical Imaging Pathology Precision Medicine

Home Page: www.hermespardini.com.br

Rua Aimorés, No. 66
Belo Horizonte, MG 30140-070
Brazil
Phone: 55 31 3228 6200


Officers

Name Title
Mr. Roberto Santoro Meirelles CEO & Member of Exec. Board
Mr. Camilo de Lelis Maciel Silva Member of Exec. Board, Chief Admin. & Financial Officer and Investor Relations Officer
Fernando Ramos Lab-to-Lab Director & Member of Exec. Board
Alessandro Clayton de Souza Ferreira VP of Commercial & Marketing and Member of Exec. Board
Guilherme Birchal Collares Exec. Director of Operations & Member of Exec. Board
Adriana Rolla Linhares Exec. Director of Bus. PSC & Member of Management Board
Mr. Joao Alvarenga IT & Digital Exec. and Member of Exec. Board
Ms. Aurea Maria Pardini Controller
Mauricio Leite Corp. Mang. of Investor Relations
Mr. Matheus Torga Investor Relations and M&A Exec. Officer

Exchange: SA

Country: BR : Brazil

Currency: Brazilian real (R$)

Forward PE: 0
Trailing PE: 15.8209
Price-to-Book MRQ: 2.7648
Price-to-Sales TTM: 1.2763
IPO Date:
Fiscal Year End: December
Full Time Employees: 7100
Back to stocks